Arch Therapeutics Inc Sustainability Reports
Arch Therapeutics, Inc. is a medical device and biotechnology company focused on developing and commercializing products based on its self-assembling peptide technology platform to stop bleeding and control fluid leakage. The company's flagship offerings include wound care and hemostasis solutions such as the AC5 Advanced Wound System.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
FIGI: BBG002PHNCN3
3 reports from 2021 to 2023
Company Profile
Arch Therapeutics, Inc. is a medical device and biotechnology company focused on developing and commercializing products based on its self-assembling peptide technology platform to stop bleeding and control fluid leakage. The company's flagship offerings include wound care and hemostasis solutions such as the AC5 Advanced Wound System.
Reports
3 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
